Connie Batlevi, MD

Connie L. Batlevi, MD, PhD, discusses the role of active surveillance in advanced​-stage follicular lymphoma. 

Connie L. Batlevi, MD, PhD, discusses emerging therapies in follicular lymphoma.

Connie L. Batlevi, MD, PhD, discusses challenges faced in the treatment of patients with follicular lymphoma.

Connie Batlevi, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses safety results of a phase I study evaluating the combination of ibrutinib (Imbruvica) and buparlisib in patients with mantle cell lymphoma (MCL), follicular lymphoma (FL), and diffuse large B-cell lymphoma (DLBCL).